CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to IPN.PA

Experimental group : Cabometyx ® (Max:), Treatment schedule : **, day 1-28 during 4 weeks (ie. 1 cycle) during 12 cycles

Phase 3
Ipsen S.A. (IPN.PA)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Osteosarcoma

View Full Landscape
Drug Information

Target Indication

Osteosarcoma

Clinical Trial

NCT07871864

Last updated: 10/16/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.